20
Cad Middle East Pharmaceutical Industries Llc Riyadh Sa, based in Saudi Arabia, is a pharmaceutical company.
One of their significant offerings is Clopidogrel hydrogen sulfate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2016-239 - Rev 00
This Chemical Type CEP, issued on December 20, 2018, remains in force until December 06, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 2531 associated with this CEP further emphasizes